Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 28, 2015
Pharmacy Choice - News - U.S. Pharmaceutical Industry - January 28, 2015

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

1/28/15 - Acceleron Pharma to Present at Upcoming Investor Conferences in February
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will participate in the following upcoming investor conferences. Live audio webcasts for the Leerink and RBC Capital Markets events will be...
1/28/15 - Aclaris Announces Positive Results from Phase 2b Clinical Trial of A-101; FDA Accepts CTD Holdings' Drug Master File
Below is a look at some of the headlines for companies that made news in the healthcare sector on January 27, 2015.{ nfg} Aclaris Therapeutics, Inc. announced positive results from a Phase 2 b clinical trial of the Company s lead drug, A-101. A-101 was well tolerated at both concentrations studied. This positive outcome represents an importan
1/28/15 - Actinium to Participate in the Canaccord Genuity Rare Disease and Biopharma One-on-One Day on February 3rd
Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Mr. Members of the investment community who are interested in meeting with management should contact Evan Smith, CFA of Actinium Pharmaceuticals at 840-5442 or...
1/28/15 - Agilent Technologies Microarray Scanner Approved for In Vitro Diagnostics in China
Release date- 27012015- SANTA CLARA, Calif.- Agilent Technologies Inc. today announced that the China Food and Drug Administration has approved the company's SureScan Dx microarray scanner as a medical device for in vitro diagnostic use. Richard Choy, associate professor at the Chinese University of Hong Kong.' Agilent's SureScan Dx scanner offers
1/28/15 - Ascendis Pharma A/S Announces Pricing of Initial Public Offering
Ascendis Pharma A/S, a clinical stage biopharmaceutical company, today announced the pricing of its initial public offering of 6,000,000 American Depositary Shares, representing 6,000,000 Ascendis ordinary shares, at a price to the public of $18.00 per ADS. BofA Merrill Lynch and Leerink Partners are acting as joint book-running managers for the
1/28/15 - Avita Medical Announces First Patient Enrollment in US Pivotal Study of ReCell(R) for the Treatment of Burns
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that the first patient has been enrolled in the Company's Pivotal Phase III burn trial for ReCell . The FDA- approved study is designed to confirm the safety and effectiveness of ReCell in patients requiring skin grafts
1/28/15 - BioPharma Services is Pleased to Announce Dr. Janice Faulknor as Their New Dedicated Medical Director
By a News Reporter-Staff News Editor at Biotech Week BioPharma Services Inc. is pleased to announce that Dr. Dr. Faulknor has held senior medical roles within Pharmaceutical Contract Research Organizations, responsible for Phase 1, SAD-MAD, and Bioequivalence studies, at CRO organizations including INC Research. "About BioPharma Services Inc.: B
1/28/15 - Cancer Treatment Centers of America at Western Regional Medical Center Launches Clinical Trial Combining Chemotherapy and Immunotherapy
By a News Reporter-Staff News Editor at Biotech Week Cancer Treatment Centers of America at Western Regional Medical Center in Goodyear, Arizona is now accepting patients into a clinical trial that combines more traditional chemotherapy drugs with immunotherapy, activating the body's own immune system to improve upon results that may be achiev
1/28/15 - Cure Duchenne Seeds Collaborative Project to Analyze the Natural History of Duchenne Muscular Dystrophy
Susan J. Ward, a consultant to BioPharma, in partnership with Dr. James Signorovitch, Vice President at Analysis Group Inc., on a collaborative project to further the understanding of the natural history of Duchenne muscular dystrophy. "Three companies are seeking FDA approval for Duchenne drugs next year, and others will be designing pivotal clin
1/28/15 - DelMar Pharmaceuticals Receives Notice of Allowance for Third US Patent for VAL-083
By a News Reporter-Staff News Editor at Biotech Week DelMar Pharmaceuticals, Inc. announced that the U.S. DelMar will provide an update on the Company's ongoing Phase I/II glioblastoma clinical trial with VAL-083 during DelMar's presentation at the Biotech Showcase Conference tomorrow at 1:45 PM Pacific Time. Keywords for this news article includ
1/28/15 - Exploring the Global Pharmaceuticals Industry Outlook to Reinforce Health Standards at 300+ OMICS International Annual Events
The sales of drug-device combination products were reached $21.4 billion in 2013 and $22 billion in 2014. This is expected to grow up to $31 billion in 2019, with a compound annual growth rate of 7.1%. North America region is the largest in generating the revenues because of U.S. pharmaceutical industry where as the European-based pharmaceutical in
1/28/15 - FACE Skincare Medical Wellness Introduces New FDA Approved Bellafill for the Treatment of Acne Scars
Recently approved by the FDA, the collagen gel in Bellafill provides immediate volume and lift using PMMA microspheres, one of the most widely used materials in medicine for 65 years. According to a recent article published on January 6, 2015, the FDA action was based on a randomized study at 10 U.S. clinical centers in which Bellafill was "foun
1/28/15 - iCura Vision Licenses First-in-Class Therapeutic Program to Treat Dry Macular Degeneration from Columbia University in Collaboration with National Institutes of Health
iCura Vision and Columbia Technology Ventures announced today that iCura Vision has licensed the intellectual property portfolio and associated research and development program for a promising oral medication intended to slow or halt the progression of "dry" Age-Related Macular Degeneration. Currently, there is no FDA- approved treatment for dry
1/28/15 - Interesting Earnings For Jan. 28
1. Northrim BanCorp, Inc. reported fourth quarter net income of $6.67 mln or $0.97 per share vs $2.68 mln or $0.40 per share a year ago. 2. Abiomed Inc., provider of breakthrough heart support technologies, said that the Impella RP System has received U.S. Food and Drug Administration approval under a Humanitarian Device Exemption or HDE. 3. Electr
1/28/15 - Ipsen Biopharmaceuticals to Present Further Data on Recently FDA-Approved Antitumor Therapy, Somatuline Depot lanreotide, at Gastrointestinal...
Ipsen Biopharmaceuticals to Present Further Data on Recently FDA-Approved Antitumor Therapy, Somatuline Depot lanreotide, at Gastrointestinal Cancers Symposium. By a News Reporter-Staff News Editor at Biotech Week Ipsen Biopharmaceuticals Inc., an affiliate of Ipsen announced three presentations of lanreotide data to be shared at the 2015..
1/28/15 - Janssen and Johnson & Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for...
Janssen and Johnson& Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease. Under terms of the agreement, facilitated by the Johnson& Johnson Innovation Center in Boston, Janssen will develop and seek to commercialize the pharmaceutical candidate in...
1/28/15 - Molecular Testing for GI Pathogens: Cost-Effectiveness, Clinical Impact and Lab Implementation, New Webinar Hosted by Nanosphere and Xtalks
The webinar will examine how rapid molecular stool pathogen diagnostic testing may minimize the burden of diarrheal illness throughout the entire hospital and to healthcare providers worldwide. Featured speakers include David Peaper, Assistant Professor of Laboratory Medicine, Yale School of Medicine; Director of Clinical Microbiology Laboratory,..
1/28/15 - Needle-Free Transdermal Delivery Startup Prometheon Pharma Opens Platform to Promote Industry Partnerships
Prometheon will optimize its proprietaryTopicon? ThermoMatrix? formulations to deliver target molecules across a robust and validated human skin model to predict if its TruePatch? product can achieve clinically meaningful bioavailability in patients. These deliverables will be owned by the collaborator, who can then choose to progress to smal
1/28/15 - New General Manager appointed to Medicines New Zealand [Kuwait News Agency]
Dr. Jarvis brings over 22 years' experience in both domestic and international private sector and government organisations. Speaking on behalf of the Board, Hon Heather Roy, Chair of Medicines New Zealand, said: We are pleased to announce the appointment of Dr. Jarvis as our new General Manager. Dr. Jarvis is pleased to be continuing his associa
1/28/15 - NPS PHARMA ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of NPS Pharmaceuticals, Inc. to Shire plc
By a News Reporter-Staff News Editor at Biotech Week Shareholder Rights Law Firm Johnson& Weaver, LLP is investigating whether members of the board of directors of NPS Pharmaceuticals, Inc. breached their fiduciary duties in connection with the planned merger of the Company with Shire plc. Moreover, one Wall Street analyst has a $48.00 price targ
1/28/15 - Patent Application Titled "Pharmaceutical Preparation-Injecting Instrument" Published Online
By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventor Saeki, Masanori, filed on February 22, 2013, was made available online on January 15, 2015. No assignee for this patent application has been made. Reporters obtained the fo
1/28/15 - Patent Issued for Crystals of Substituted Cycloalkene Derivatives
By a News Reporter-Staff News Editor at Biotech Week A patent by the inventors Ohkawa, Nobuyuki; Iida, Kouki; Nagasaki, Takayoshi, filed on September 22, 2011, was published online on January 13, 2015, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 8933117 is assigned to Daiichi Sankyo C
1/28/15 - Patent Issued for Fluoroergoline Analogs
By a News Reporter-Staff News Editor at Biotech Week Map Pharmaceuticals, Inc. has been issued patent number 8933093, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Cook, Robert O.; Zhang, Jian; Armer, Thomas A.. This patent was filed on October 7, 2013 and was published online o
1/28/15 - Patent Issued for Glucagon-Like Peptide-2 Analogs
By a News Reporter-Staff News Editor at Journal of Engineering From Alexandria, Virginia, VerticalNews journalists report that a patent by the inventors Drucker, Daniel J; Crivici, Anna E.; Sumner-Smith, Martin, filed on June 15, 2010, was published online on January 13, 2015. The patent's assignee for patent number 8933039 is NPS Pharmaceuticals
1/28/15 - Patent Issued for Inhaler
By a News Reporter-Staff News Editor at Journal of Engineering A patent by the inventors Kaar, Simon; Walsh, Declan; Fenlon, Derek; Buck, Dan, filed on June 8, 2010, was published online on January 13, 2015, according to news reporting originating from Alexandria, Virginia, by VerticalNews correspondents. Patent number 8931476 is assigned to IVAX
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Drug Therapy Management Series Part I: Cardiovascular Disorders
This lesson is supported by:
RxSchool
Workplace Safety & Joint Commission Standards for Pharmacy Professionals
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415